CT FOR ADDICTION AND MENTAL HEALTH has a total of 13 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Canada, EPO (European Patent Office) and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are NEKONAL S A R L, NYXIS NEUROTHERAPIES INC and CELL SIGNALING TECHNOLOGY INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 6 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Measuring microorganism processes | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials | |
#5 | Medical preparations | |
#6 | Microorganisms | |
#7 | Enzymes | |
#8 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Liu Fang | 5 |
#2 | Petronis Arturas | 4 |
#3 | Cortese Rene | 3 |
#4 | Vincent John B | 2 |
#5 | Kennedy James Lowery | 2 |
#6 | Macciardi Fabio | 1 |
#7 | Mundo Emanuela | 1 |
#8 | Schumacher Axel | 1 |
Publication | Filing date | Title |
---|---|---|
CA2802919A1 | Genetic markers associated with intellectual disability | |
EP2483426A1 | Method for analysis of dna methylation profiles of cell-free circulating dna in bodily fluids | |
EP2417154A1 | Dopamine d2 receptor-disc1 interaction, compositions and methods for modulating same | |
CA2344093A1 | Detection of antidepressant induced mania |